Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drugs - Generic Sector (CIX: MSECTOR512)
2,409.43   -44.10 (-1.80%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 2448.29
Prev. Close 2453.53
Today's Range 2398.58 - 2449.49
52wk Range 1922.89 - 2628.49
Components
View All
Value % Change
Mylan, Inc.  31.18
-1.81%
Hi-Tech Pharmacal Co, Inc.  33.70
-1.98%
Catyalyst Pharmaceutical Partners, Inc.  0.8799
+5.38%
RXElite, Inc.  0.0004
0.00%
Top News
More News
Examining Block Trading Activity & Unusual Options Volume for Mylan
May 24, 2013
NEW YORK (AVAFIN) -- Block trades help investors understand the sentiment of large financial ... Read More
from AVAFIN
HITK Makes Bullish Cross Above Critical Moving Average
May 22, 2013
In trading on Wednesday, shares of HI-Tech Pharmacal Co., Inc. (HITK) crossed above their 200 day moving average of $34.35, changing hands as high as $34.57 per share. Read More
from Market News Video
Trading Update for Mylan
May 22, 2013
NEW YORK (AVAFIN) -- Mylan witnessed a record number of call and put contracts ... Read More
from AVAFIN
More News
More News
Bernstein Believes Mylan Could Offer $22/Share for Warner Chilcott, Calls Deal with Actavis More Likely
May 21, 2013
Bernstein analyst Aaron Gal issued a note Tuesday morning suggesting Warner Chilcott's (NASDAQ: WCRX ) "willingness" for an all-share deal could cause other suitors to jump in for a possible bid. The... Read More
from Latest Articles from Benzinga.com
"Modern Family" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition
May 21, 2013
Total of $60,000 Will Be Awarded to School Districts In Educational Grants Recommended for Anaphylaxis Education Read More
from PR Newswire
Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product
May 21, 2013
from PR Newswire
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354040 for the full story. Read More
from StreetInsider.com News Articles
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
On Monday, generic drug maker Actavis Inc. (NYSE: ACT ) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX ) in an all-stock deal valued around $8.5 billion.... Read More
from Latest Articles from Benzinga.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here